Dillico attended to the 3rd mRNA Process Development & Manufacturing Summit in Boston this September 17-19.
Our CEO, Christophe BONNEVILLE, talked about the development of a Continuous Manufacturing Solution for All-Scale mRNA-LNP Production, at Dillico. This was the opportunity to present to the mRNA ecosystem how Dillico is:
- Overcoming the challenge of scalability in the mRNA landscape
- Implementing robust continuous processes and control strategies
- Accelerating process development at optimal cost with Process Modeling